TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
RZLT

Rezolute Inc

Healthcare · Biotechnology

4.00$ -1.0% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Rezolute Inc (RZLT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 125 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RZLT
Line item Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
124 113 102 88 133 123 112 95 175 159 139 125
105 103 96 82 129 110 99 89 171 155 135 122
16 8.1 13 5.9 70 10 8.9 15 94 9.1 12 11
102 99 93 80 127 108 97 87 168 152 133 120
0.7 0.6 0.6
2.2
7.5 9.4 10 17 12 10.0 12 12 13 11 11 8.6
5.2 7.2 8.0 7.0 9.6 8.0 11 11 12 10 9.5 7.7
0.5 0.5 0.5 0.6 0.6 0.6 0.6 0.6 0.6 0.7 0.7 0.7
3.3 2.4 3.6 3.5 4.9 2.2 3.1 6.5 5.8 3.3 3.8 3.2
116 104 92 71 121 113 100 83 162 147 128 117
-261 -276 -289 -306 -329 -345 -361 -379 -404 -422 -445 -461
51 51 51 51 51 70 70 70 94 103 104 104

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?